jnis.bmj1d
P-016 Successful Flow Diversion of Cerebral Aneurysms in Plavix Hyporesponders (PRU ≥ 200): An Argument for Antiplatelet Monotherapy?
Introduction Endovascular aneurysm treatment by flow diversion has classically relied on dual anti-platelet therapy with Aspirin and Plavix to reduce thrombotic complications. The heterogenous Plavix ...
jnis.bmj1d
Transarterial and transvenous access for neurointerventional surgery: report of the SNIS Standards and Guidelines Committee
Correspondence to Dr Justin F Fraser, Neurological Surgery, University of Kentucky, Lexington, KY 40536, USA; Jfr235{at}uky.edu ...
jnis.bmj1d
Can early neurological improvement after mechanical thrombectomy be used as a surrogate for final stroke outcome?
Background and purpose We aimed to identify the best definition of early neurological improvement (ENI) at 2 and 24 hours after mechanical thrombectomy (MT) and determine its ability to predict a good ...
jnis.bmj2d
Early neurologic decline in acute ischemic stroke patients receiving thrombolysis with large vessel occlusion and mild deficits
Correspondence to Dr Vivien H Lee, Neurology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; vivien.lee{at}osumc.edu Background We sought to determine the rate of early ...
jnis.bmj2d
Initial clinical experience with the ADAPT technique: A direct aspiration first pass technique for stroke thrombectomy
1 Department of Radiology, Medical University of South Carolina, Charleston, South Carolina, USA 2 Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina, USA 3 ...
jnis.bmj2d
Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification
Background Flow diverters offer a promising treatment for cerebral aneurysms. However, they have associated thromboembolic risks, mandating chronic dual antiplatelet therapy (DAPT). Shield Technology ...
jnis.bmj2d
Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology
Background The Pipeline Vantage Embolization Device with Shield Technology is a next generation flow diverter developed to improve aneurysm occlusion and implant endothelialization in addition to ...
jnis.bmj3d
Woven EndoBridge device for ruptured aneurysms: perioperative results of a US multicenter experience
Background The Woven EndoBridge (WEB) device is approved in the USA for treatment of unruptured wide-neck bifurcation aneurysms. However, the safety and effectiveness of the WEB device in the ...
jnis.bmj3d
Treatment of ruptured intracranial aneurysms with the Woven EndoBridge device: a systematic review
Correspondence to Dr Adnan H Siddiqui, Neurosurgery and Radiology and Canon Stroke and Vascular Research Center, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY ...
jnis.bmj3d
Mechanical thrombectomy in patients with acute ischemic stroke and ASPECTS ≤6: a meta-analysis
Background It is uncertain whether mechanical thrombectomy (MT) increases the probability of a good outcome (modified Rankin Scale (mRS) 0–2) in patients with Alberta Stroke Program Early CT Score ...